Recent developments in the molecular genetic understanding of breast cancer.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Critical reviews in oncogenesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1615/CRITREVONCOG.V5.I2-3.70PMID 7849087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two distinct regions involved in 1p deletion in human primary breast cancer.

  1993cited by this paper
• Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.

  1993cited by this paper
• Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.

  1993cited by this paper
• High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases

  1993cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

  1993cited by this paper
• High rate of multilocus deletion in a human tumor cell line.

  1993cited by this paper
• Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

  1993cited by this paper
• A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.

  1993cited by this paper
• DNA amplification at 11q13.5-q14 in human breast cancer.

  1992cited by this paper
• p53 mutations in breast cancer.

  1992cited by this paper
• Three distinct regions involved in 3p deletion in human lung cancer.

  1992cited by this paper
• One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

  1992cited by this paper
• p53 mutations occur in aggressive breast cancer.

  1992cited by this paper
• Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

  1992cited by this paper
• Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.

  1992cited by this paper
• Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

  1992cited by this paper
• Wild-type p53 activates transcription in vitro

  1992cited by this paper
• Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells.

  1992cited by this paper
• No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.

  1992cited by this paper
• The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer.

  1992cited by this paper
• Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

  1992cited by this paper
• Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome

  1992cited by this paper
• Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas

  1992cited by this paper
• Detailed analysis of an amplified region at chromosome 11q13 in malignant tumors.

  1992cited by this paper
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

  1992cited by this paper
• Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss

  1992cited by this paper
• Linkage map of a region of human chromosome band 11q13 amplified in breast and squamous cell tumors

  1992cited by this paper
• The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

  1992cited by this paper
• c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

  1992cited by this paper
• Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately.

  1992cited by this paper
• Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

  1992cited by this paper
• Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

  1992cited by this paper
• Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

  1992cited by this paper
• Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.

  1992cited by this paper
• Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

  1992cited by this paper
• Abnormal expression of wild type p53 protein in normal cells of a cancer family patient.

  1992cited by this paper
• Family history and risk of breast cancer.

  1992cited by this paper
• DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.

  1992cited by this paper
• The retinoblastoma protein and cell cycle regulation.

  1992cited by this paper
• Heterogeneity for allelic loss in human breast cancer.

  1992cited by this paper
• Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer.

  1992cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.

  1992cited by this paper
• Epidemiology of breast cancer in families in Iceland.

  1992cited by this paper
• Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.

  1992cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression.

  1992cited by this paper
• Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.

  1992cited by this paper
• Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.

  1992cited by this paper
• Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.

  1991cited by this paper
• c-erbB-2 oncoprotein expression in primary and advanced breast cancer.

  1991cited by this paper
• Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.

  1991cited by this paper
• BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.

  1991cited by this paper
• A germ line mutation in exon 5 of the p53 gene in an extended cancer family.

  1991cited by this paper
• Amplification at chromosome 11q13 in transitional cell tumours of the bladder.

  1991cited by this paper
• The molecular biology of breast cancer.

  1991cited by this paper
• Characterization of a neu/c-erbB-2 protein-specific activating factor.

  1991cited by this paper
• Chromosome 11q13 abnormalities in human cancer.

  1991cited by this paper
• p53 germline mutations in Li-Fraumeni syndrome.

  1991cited by this paper
• Loss of constitutional heterozygosity in human cancer.

  1991cited by this paper
• Somatic allelic deletion of nm23 in human cancer.

  1991cited by this paper
• Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

  1991cited by this paper
• Biological correlation between HER-2/neu and proliferative activity in human breast cancer.

  1991cited by this paper
• Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.

  1991cited by this paper
• Mutations in p53 do not account for heritable breast cancer: a study in five affected families.

  1991cited by this paper
• Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.

  1991cited by this paper
• Breast cancer genetic evolution: I. Data from cytogenetics and DNA content

  1991cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidy

  1991cited by this paper
• Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.

  1991cited by this paper
• Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.

  1991cited by this paper
• Mutations in the p53 gene in primary human breast cancers.

  1991cited by this paper
• Expression of p53 protein in infiltrating and in‐situ breast carcinomas

  1991cited by this paper
• Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma

  1991cited by this paper
• Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Genetic basis for p53 overexpression in human breast cancer.

  1991cited by this paper
• Familial breast-ovarian cancer locus on chromosome 17q12-q23.

  1991cited by this paper
• D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.

  1991cited by this paper
• D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer.

  1991cited by this paper
• Accumulation of genetic alterations and progression of primary breast cancer.

  1991cited by this paper
• Loss of heterozygosity of the L-myc oncogene in human breast tumors

  1990cited by this paper
• Stochastic model for interpreting the data on loss of heterozygosity in breast cancer.

  1990cited by this paper
• Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

  1990cited by this paper
• Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysis

  1990cited by this paper
• Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer.

  1990cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.

  1990cited by this paper
• Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

  1990cited by this paper
• Different tumor-derived p53 mutants exhibit distinct biological activities.

  1990cited by this paper
• Genetics of human breast cancer.

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Genetic mechanisms of tumor suppression by the human p53 gene

  1990cited by this paper
• The locus of the polymorphic epithelial mucin (PEM) tumour antigen on chromosome 1q21 shows a high frequency of alteration in primary human breast tumours

  1990cited by this paper
• Genomic alterations in human breast carcinomas

  1990cited by this paper
• Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

  1990cited by this paper
• Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

  1990cited by this paper
• Tumor suppressor genes: the puzzle and the promise.

  1989cited by this paper

• A Deep Learning Model for Predicting Molecular Subtype of Breast Cancer by Fusing Multiple Sequences of DCE-MRI From Two Institutes.

  2024cites this paper
• Expression of circadian clock genes in human colorectal adenoma and carcinoma

  2017cites this paper
• N-Methyl-N-nitrosourea as a mammary carcinogenic agent

  2015cites this paper
• TYROSINE KINASE AS TARGET FOR CANCER TREATMENT

  2014influential citation
• A Genomewide Screen for Suppressors of Alu-Mediated Rearrangements Reveals a Role for PIF1

  2012cites this paper
• Chromosomal alterations and telomere dysfunction in breast tumours

  2008influential citation
• Region at 11 q 23 . 3 of Heterozygosity in Breast Cancer : Identification of a New Definition and Refinement of Chromosome 11 Regions of Loss Updated

  2006cites this paper
• Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

  2006cites this paper
• Mutation Found in Breast Cancer 1

  2006cites this paper
• Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.

  2005cites this paper
• Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas.

  2004cites this paper
• Haploid Inactivation of the Amplified-in-Breast Cancer 3 Coactivator Reduces the Inhibitory Effect of Peroxisome Proliferator-Activated Receptor γ and Retinoid X Receptor on Cell Proliferation and Accelerates Polyoma Middle-T Antigen-Induced Mammary Tumorigenesis in Mice

  2004cites this paper
• Methods for the molecular analysis of cancer

  2003cites this paper
• P53 codon 72 polymorphism in breast cancer.

  2003cites this paper
• CONCORDANC EO FALLELI CIMBALANC EPROFILE SI NSYNCHRONOU SAND METACHRONOU SBILATERA LBREAS TCARCINOMAS

  2002cites this paper
• Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas

  2002cites this paper
• Are surgeons effective counsellors for women with a family history of breast cancer?

  2002cites this paper
• Molecular Analysis of Cancer

  2002cites this paper
• Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis

  2002cites this paper
• Association of steroid receptor coactivator AIB1 with estrogen receptor-α in breast cancer cells

  2001cites this paper
• Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor

  2001cites this paper
• Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.

  2001cites this paper
• Mammary Tumor Induction and Premature Ovarian Failure in ApcMin Mice Are Not Enhanced by Brca2 Defi ciency

  2001cites this paper
• Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.

  2001cites this paper
• Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis

  2001cites this paper
• Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.

  2001cites this paper
• A comparison of clinico-biological and genetic markers in sporadic breast cancer in different populations

  2000cites this paper
• Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer.

  1999cites this paper
• Differentially expressed genes associated with the metastatic phenotype in breast cancer

  1999cites this paper
• Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.

  1999cites this paper
• Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer

  1999cites this paper
• Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat

  1999cites this paper
• Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage

  1999cites this paper
• PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation.

  1999cites this paper
• Allelic instability as a predictor of survival in Egyptian breast cancer patients.

  1999cites this paper
• Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.

  1999cites this paper
• Suppression of ING1 expression in sporadic breast cancer

  1999cites this paper
• Oncogenes and Mammary Carcinogenesis

  1999cites this paper
• Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas

  1998cites this paper
• Molecular epidemiology of breast cancer.

  1998cites this paper
• Alterations in the Ha‐ras‐1 and the p53 pathway genes in the progression of N‐methyl‐N‐nitrosourea–induced rat mammary tumors

  1997cites this paper
• Tumor suppressor genes and human cancer.

  1997cites this paper
• Optimizing DOP‐PCR for universal amplification of small DNA samples in comparative genomic hybridization

  1997cites this paper
• Molecular analysis of INK4 genes in breast carcinomas.

  1997cites this paper
• Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.

  1997cites this paper
• Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters

  1997cites this paper
• Breast Tumor Cytogenetic Markers

  1997cites this paper
• Telomerase activity in normal and neoplastic breast.

  1997cites this paper
• Alterations in expression of the motility-related proteins thymosin BETA 15 and P120CAS in human cancer

  1997cites this paper
• A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

  1997cites this paper
• The Identification of Genetic Alterations in Pre-Invasive Breast Cancer

  1997cites this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cites this paper
• Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.

  1996cites this paper
• Genetic divergence in the clonal evolution of breast cancer.

  1996cites this paper
• Mutations in the BRCA2 gene in hepatocellular carcinomas.

  1996cites this paper
• Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.

  1996influential citation
• Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.

  1996cites this paper
• Cumulative regional allelotyping of human breast carcinomas.

  1996cites this paper
• Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.

  1996cites this paper
• p27/Kip1 mutation found in breast cancer.

  1996cites this paper
• Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

  1996cites this paper
• Breast Cancer Cytogenetics: Clues to Genetic Complexity of the Disease

  1996cites this paper
• p27/Kipl Mutation Found in Breast Cancer1

  1996cites this paper
• Detection of frequent allelic loss of 6q23–q25.2 in microdissected human breast cancer tissues

  1996cites this paper
• Breast Cancer Cytogenetics: Clues to Genetic Complexity of the Disease

  1996cites this paper
• Chromosomal instability and alteration of telomere repeat sequences.

  1995cites this paper
• Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

  1995cites this paper
• Molecular genetics of sporadic and familial breast cancer.

  1995cites this paper
• Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

  1995cites this paper
• T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy.

  1995cites this paper
• Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.

  1995cites this paper